These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29860057)

  • 1. Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial.
    Briones M; Shoptaw S; Cook R; Worley M; Swanson AN; Moody DE; Fang WB; Tsuang J; Furst B; Heinzerling K
    Drug Alcohol Depend; 2018 Aug; 189():30-36. PubMed ID: 29860057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.
    Verrico CD; Mahoney JJ; Thompson-Lake DG; Bennett RS; Newton TF; De La Garza R
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):223-33. PubMed ID: 24393456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
    Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
    JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.
    Kalechstein AD; Mahoney JJ; Verrico CD; De La Garza R
    Neuropharmacology; 2014 Oct; 85():493-8. PubMed ID: 24930359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial.
    de Bejczy A; Löf E; Walther L; Guterstam J; Hammarberg A; Asanovska G; Franck J; Isaksson A; Söderpalm B
    Alcohol Clin Exp Res; 2015 Nov; 39(11):2189-99. PubMed ID: 26414337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline for the Treatment of Cocaine Dependence.
    Lynch KG; Plebani J; Spratt K; Morales M; Tamminga M; Feibush P; Kampman KM
    J Addict Med; 2022 Mar-Apr 01; 16(2):157-163. PubMed ID: 33840773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
    O'Malley SS; Zweben A; Fucito LM; Wu R; Piepmeier ME; Ockert DM; Bold KW; Petrakis I; Muvvala S; Jatlow P; Gueorguieva R
    JAMA Psychiatry; 2018 Feb; 75(2):129-138. PubMed ID: 29261824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.
    Plebani JG; Lynch KG; Yu Q; Pettinati HM; O'Brien CP; Kampman KM
    Drug Alcohol Depend; 2012 Feb; 121(1-2):163-6. PubMed ID: 21925806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.
    Brensilver M; Heinzerling KG; Swanson AN; Shoptaw SJ
    Exp Clin Psychopharmacol; 2012 Oct; 20(5):430-5. PubMed ID: 22867036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence.
    Zorick T; Sevak RJ; Miotto K; Shoptaw S; Swanson AN; Clement C; De La Garza R; Newton TF; London ED
    J Exp Pharmacol; 2010; 2():13-8. PubMed ID: 27186086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial.
    Farahzadi MH; Moazen-Zadeh E; Razaghi E; Zarrindast MR; Bidaki R; Akhondzadeh S
    J Psychopharmacol; 2019 Mar; 33(3):305-315. PubMed ID: 30526230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.